Skip to content
OCX Oncocyte Corporation Common Stock
$0.00 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy OCX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 37.5M
Enterprise value 30.9M
Trailing PE -0.59466667175293
Forward PE -1.2890173
PEG Ratio -1.2890173
Enterprise to EBITDA -1.435
Enterprise to revenue 43.633
Price to book MRQ 3.1497176
Price to sales TTM 52.951336

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 709K
EBITDA -21556000
Diluted EPS TTM -4.44
Total Cash (MRQ) 3.4M
Current ratio (MRQ) 0.527
Operating Cash Flow (TTM) -21293000

OCX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent OCX News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.